Qin H - Search Results

1

Third-line or above anlotinib in relapsed and refractory small cell lung cancer patients with brain metastases: A post hoc analysis of ALTER1202, a randomized, double-blind phase 2 study.

Cheng Y, Wang Q, Li K, Shi J, Han B, Wu L, Chen G, He J, Wang J, Qin H, Li X. Cheng Y, et al. Among authors: qin h. Cancer Innov. 2023 Jan 17;2(3):181-190. doi: 10.1002/cai2.43. eCollection 2023 Jun. Cancer Innov. 2023. PMID: 38089404 Free PMC article.

2

Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study.

Cheng Y, Wang Q, Li K, Shi J, Liu Y, Wu L, Han B, Chen G, He J, Wang J, Lou D, Yu H, Wang S, Qin H, Li X. Cheng Y, et al. Among authors: qin h. Br J Cancer. 2021 Aug;125(3):366-371. doi: 10.1038/s41416-021-01356-3. Epub 2021 May 18. Br J Cancer. 2021. PMID: 34006926 Free PMC article. Clinical Trial.

3

Effectiveness of anlotinib in patients with small-cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study.

Liu Y, Cheng Y, Wang Q, Li K, Shi J, Wu L, Han B, Chen G, He J, Wang J, Qin H, Li X. Liu Y, et al. Among authors: qin h. Thorac Cancer. 2021 Nov;12(22):3039-3045. doi: 10.1111/1759-7714.14176. Epub 2021 Oct 1. Thorac Cancer. 2021. PMID: 34596367 Free PMC article. Clinical Trial.

4

Effect of prior thoracic radiotherapy on prognosis in relapsed small cell lung cancer patients treated with anlotinib: a subgroup analysis of the ALTER 1202 trial.

Liu Y, Cheng Y, Li K, Shi J, Liu Y, Wu L, Han B, Chen G, He J, Wang J, Qin H, Li X, Hamaji M, Park HS. Liu Y, et al. Among authors: qin h. Transl Lung Cancer Res. 2021 Sep;10(9):3793-3806. doi: 10.21037/tlcr-21-632. Transl Lung Cancer Res. 2021. PMID: 34733629 Free PMC article.

5

Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial.

Cheng Y, Wang Q, Li K, Shi J, Wu L, Han B, Chen G, He J, Wang J, Qin H, Li X. Cheng Y, et al. Among authors: qin h. Cancer Med. 2022 Feb;11(4):1081-1087. doi: 10.1002/cam4.4507. Epub 2021 Dec 23. Cancer Med. 2022. PMID: 34939373 Free PMC article. Clinical Trial.

6

Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup analysis of a randomized phase 2 study (ALTER1202).

Shi J, Cheng Y, Wang Q, Li K, Wu L, Han B, Chen G, He J, Wang J, Qin H, Li X. Shi J, et al. Among authors: qin h. Front Med. 2022 Oct;16(5):766-772. doi: 10.1007/s11684-021-0916-8. Epub 2022 Jul 16. Front Med. 2022. PMID: 35844026 Clinical Trial.

7

Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung.

Wang S, Chen H, Zhong J, Qin H, Bai H, Zhao J, Wang J. Wang S, et al. Among authors: qin h. Lung Cancer. 2019 Sep;135:116-122. doi: 10.1016/j.lungcan.2019.05.018. Epub 2019 May 16. Lung Cancer. 2019. PMID: 31446983

8

Corrigendum to "Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung" [Lung Cancer 135 (2019) 116-122].

Wang S, Chen H, Zhong J, Qin H, Bai H, Zhao J, Wang J. Wang S, et al. Among authors: qin h. Lung Cancer. 2021 Mar;153:196. doi: 10.1016/j.lungcan.2021.01.008. Epub 2021 Feb 3. Lung Cancer. 2021. PMID: 33546909 No abstract available.

9

Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study.

Zhang K, Ma X, Gao H, Wang H, Qin H, Yang S, Liu X. Zhang K, et al. Among authors: qin h. Cancer Manag Res. 2020 May 13;12:3409-3417. doi: 10.2147/CMAR.S246000. eCollection 2020. Cancer Manag Res. 2020. PMID: 32494205 Free PMC article.

10

Efficacy of different sequential patterns after crizotinib progression in advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.

Ma X, Yang S, Zhang K, Xu J, Lv P, Gao H, Qin H, Wang H, Liu X. Ma X, et al. Among authors: qin h. Thorac Cancer. 2022 Jun;13(12):1788-1794. doi: 10.1111/1759-7714.14455. Epub 2022 May 13. Thorac Cancer. 2022. PMID: 35560808 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,751 results

Search Page

Filters